Bipolar Depression Clinical Trials
LURASIDONE as Adjunctive Treatment with LITHIUM OR DIVALPROEX
Eligibility
Adults (18-75 years old) with a diagnosis of bipolar I depressionBipolar patients are currently taking lithium or depakote
Outpatient only
Patient Benefits
Eligible participants may receive at no cost, study medication, study-related physical exam, lab work and compensation for time and travel
MRI STUDY involving treatment with SEROQUEL or LITHIUM CARBONATE for Adults and Adolescents with Bipolar I Disorder
Eligibility
Adults and adolescents (12-35 years old) with a diagnosis of bipolar I disorder and are manic, mixed, or depressed
MRI brain scan required
Patient Benefits
Eligible participants may receive at no cost, study medication, study-related physical exam, lab work and compensation for time and travel, and MRI brain scans
LITHIUM study for Adolescents and Adults with Bipolar I Disorder
Eligibility
Adults and adolescents (15-55 years old) with a diagnosis of bipolar I disorder and are manic, mixed, or depressed
MRI brain scan required
Patient Benefits
Eligible participants may receive at no cost, study medication, study-related physical exam, lab work, compensation for time and travel
OMEGA-3 Study for Children and Young Adults with Major Depression At-Risk for Bipolar Disorder
Eligibility
Children through young adults (10-21 years old) with a diagnosis of major depressive disorder
Participants must have at least one biological parent that has bipolar I disorder
Outpatient only
MRI brain scan required
Patient Benefits
Eligible participants may receive compensation for their time and travel.
FOR MORE INFORMATION on any of the above studies, please contact:
Holly Bryan
Office: 513-558-3191
Pager: 230-0785
More Information
Clinical Research Management
Amelia Nasrallah, Director
University of Cincinnati Academic Health Center
Department of Psychiatry and Behavioral Neuroscience
PO Box 670559
Cincinnati, Ohio 45267-0559
Phone: (513) 558-2226
Fax: (513) 558-4616
Email: amelia.nasrallah@uc.edu